Background
Fidelity National Financial, Inc. (FNF), a title insurance and real estate services company, was a Delaware corporation until it re-domesticated to Nevada on June 11, 2025. One day before that re-domestication, stockholder Patrick Ayers filed this derivative action challenging two categories of compensation decisions by the FNF board: (1) a bespoke $50 million equity grant to William P. Foley—FNF’s founder, 3.6% stockholder, and Non-Executive Chairman—designed to retain him through 2027 after he publicly signaled interest in stepping back from public company roles; and (2) annual compensation increases the board’s Compensation Committee approved for itself in 2022, 2023, and 2024, which plaintiff alleged were excessive and untethered to peer-relative financial performance.
The Foley equity grant arose after Compensation Committee members approached Foley following a MarketWatch article in which he indicated he was “going back to a private environment.” After Foley initially requested a $60 million grant, negotiations mediated by committee members resulted in a $50 million restricted stock award vesting over three years, with 25% vesting immediately. Because of the grant’s magnitude, the Compensation Committee conditioned its approval on concurrence from the Related Person Transaction (RPT) Committee, which subsequently reviewed independent market data, obtained an SCG independence analysis, and received a legal memorandum from FNF’s General Counsel before approving the grant by email on October 28, 2024. Plaintiff characterized the RPT Committee’s review as an empty formality and advanced a “quid pro quo” theory—that the NEDs approved Foley’s windfall in exchange for his acquiescence to their own pay increases—before abandoning that theory at oral argument.
All eleven board members except Executive Vice Chairman Raymond Quirk were named as defendants. Nine non-employee directors (NEDs) had been determined to satisfy NYSE independence standards. The defendants moved to dismiss under Court of Chancery Rules 23.1 (demand futility) and 12(b)(6) (failure to state a claim). Vice Chancellor Will resolved the motion in a split decision on June 15, 2026.
The Court’s Holding
The court dismissed all claims relating to Foley’s $50 million equity grant. It first held that the equity grant and the NED compensation increases were separate, independently approved transactions that could not be conflated for demand futility purposes. Unlike Investors Bancorp, where the entire board jointly approved all compensation components in a unified process, FNF’s two compensation actions diverged procedurally: NED pay was finalized by the Compensation Committee on October 14, while the equity grant proceeded through a separate RPT Committee process concluding two weeks later. The RPT Committee’s involvement was valid—the Incentive Plan expressly permits delegation “as permitted by law,” and no particularized facts showed the referral was empty formalism. Treating the grants as one transaction would also improperly collapse the safe harbor in 8 Del. C. § 144(a)(1), which applies on an act-by-transaction basis.
Applying the Zuckerberg demand-futility test only to the equity grant, the court found that the plaintiff failed to plead a conflicted board majority. Foley himself was concededly interested (he received the grant), but the nine NYSE-independent NEDs were entitled to the heightened statutory presumption of disinterestedness codified in newly amended 8 Del. C. § 144(d)(2). The plaintiff’s particularized allegations as to Ammerman, Hagerty, and Rood—the three directors whose independence was specifically tested—fell short of the “substantial and particularized facts” standard required to rebut that presumption, leaving the plaintiff without a conflicted majority. The court also found that plaintiff failed to plead bad faith adequate to survive the combined protection of § 144(a)(1)’s safe harbor and FNF’s § 102(b)(7) exculpatory charter provision, so the substantial-likelihood-of-liability prong likewise did not rescue demand excusal.
The director self-compensation claims fared differently. Because Compensation Committee members were inherently interested when setting their own pay, the court applied entire fairness review absent a compliant stockholder ratification vote under § 144(a)(2). At the pleading stage, the plaintiff sufficiently alleged both unfair dealing and an unfair price to state a breach of fiduciary duty claim against the directors who actually voted to approve the compensation packages. However, directors who merely received—but did not vote to approve—their own compensation did not face sufficient liability exposure; the breach of fiduciary duty claims against passive recipients were dismissed. The unjust enrichment claim survived against all director defendants who retained the challenged compensation awards.
Key Takeaways
- Newly amended 8 Del. C. § 144(d)(2) sets a demanding, heightened standard for pleading that NYSE-independent directors lack disinterestedness; generalized allegations of social ties or business relationships will not suffice to rebut the statutory presumption.
- Two compensation decisions considered at the same board meeting can still be legally distinct transactions for demand futility analysis if they involve different directors, different processes, and different approval timelines — Investors Bancorp‘s unified-process theory does not apply where one decision is delegated to a separate committee that acts independently and later.
- A § 144(a)(1) safe harbor for a specific “act or transaction” cannot be disabled by alleging that a contemporaneous but independent transaction was conflicted; importing conflict from one action into another would frustrate the General Assembly’s intent.
- Director self-compensation is subject to entire fairness scrutiny absent proper stockholder ratification, and the approving committee members—not merely passive recipients—face breach of fiduciary duty exposure; unjust enrichment claims, however, survive against all directors who retained the challenged pay.
- A derivative plaintiff who abandons a core legal theory (here, the quid pro quo) at oral argument cannot rehabilitate demand excusal by reframing the same facts under a different legal label.
Why It Matters
This decision is one of the first substantive applications of Delaware’s amended § 144 to the derivative demand futility context, and it signals that the statute’s heightened presumption of independence for exchange-listed directors carries real bite at the pleading stage. Plaintiffs challenging compensation decisions involving NYSE-independent directors must now marshal particularized, substantial facts of a material relationship—not merely inference from overlapping affiliations—before they can overcome the presumption and survive a Rule 23.1 motion. The opinion also offers practical guidance on structuring large related-party grants: routing a significant executive award through a genuinely deliberate RPT Committee process, with independent market data and legal analysis, can sever the grant from concurrent NED compensation decisions and insulate both from a unified demand-futility attack.
The survival of the director self-compensation claims reinforces the well-settled principle that boards approving their own pay occupy an inherently conflicted position and cannot escape entire fairness review without a stockholder vote. For corporate practitioners, the opinion underscores the importance of separating executive-retention grants from annual NED pay cycles—procedurally and temporally—and of ensuring that any delegated approval body conducts a genuine, documented independent review rather than a rubber-stamp ratification.